HDGFL1
gene geneOn this page
Also known as dJ309H15.1Hdgfrp1HRP-1
Summary
HDGFL1 (HDGF like 1, HGNC:21095) is a protein-coding gene on chromosome 6p22.3, encoding Hepatoma-derived growth factor-like protein 1 (Q5TGJ6).
Predicted to be involved in chromatin remodeling. Predicted to be active in nucleus.
Source: NCBI Gene 154150 — RefSeq curated summary.
At a glance
- GWAS associations: 15
- Clinical variants (ClinVar): 54 total
- MANE Select transcript:
NM_138574
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21095 |
| Approved symbol | HDGFL1 |
| Name | HDGF like 1 |
| Location | 6p22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ309H15.1, Hdgfrp1, HRP-1 |
| Ensembl gene | ENSG00000112273 |
| Ensembl biotype | protein_coding |
| Entrez | 154150 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000510882
RefSeq mRNA: 1 — MANE Select: NM_138574
NM_138574
CCDS: CCDS34347
Canonical transcript exons
ENST00000510882 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002081119 | 22569566 | 22571666 |
Expression profiles
Bgee: expression breadth broad, 52 present calls, max score 96.49.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4416 / max 392.4439, expressed in 6 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 66367 | 0.3145 | 6 |
| 66366 | 0.1161 | 4 |
| 66365 | 0.0109 | 3 |
Top tissues by expression
171 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 96.49 | gold quality |
| left testis | UBERON:0004533 | 95.84 | gold quality |
| right testis | UBERON:0004534 | 95.76 | gold quality |
| adult organism | UBERON:0007023 | 93.49 | gold quality |
| testis | UBERON:0000473 | 93.02 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 90.77 | gold quality |
| secondary oocyte | CL:0000655 | 90.57 | gold quality |
| ileal mucosa | UBERON:0000331 | 90.54 | silver quality |
| tibialis anterior | UBERON:0001385 | 90.36 | silver quality |
| left ventricle myocardium | UBERON:0006566 | 90.03 | gold quality |
| pancreatic ductal cell | CL:0002079 | 88.04 | silver quality |
| oocyte | CL:0000023 | 87.85 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.14 | gold quality |
| upper arm skin | UBERON:0004263 | 83.90 | gold quality |
| deltoid | UBERON:0001476 | 83.23 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.61 | gold quality |
| cardia of stomach | UBERON:0001162 | 79.57 | silver quality |
| kidney epithelium | UBERON:0004819 | 79.55 | gold quality |
| vena cava | UBERON:0004087 | 79.36 | silver quality |
| quadriceps femoris | UBERON:0001377 | 78.04 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 77.19 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 77.14 | gold quality |
| myocardium | UBERON:0002349 | 77.02 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 76.49 | gold quality |
| vastus lateralis | UBERON:0001379 | 76.34 | gold quality |
| ventral tegmental area | UBERON:0002691 | 76.15 | silver quality |
| pharyngeal mucosa | UBERON:0000355 | 76.05 | silver quality |
| pons | UBERON:0000988 | 75.14 | silver quality |
| superior surface of tongue | UBERON:0007371 | 75.10 | silver quality |
| inferior vagus X ganglion | UBERON:0005363 | 74.99 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
3 targeting HDGFL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-7160-5P | 99.11 | 67.17 | 2207 |
Literature-anchored findings (GeneRIF, showing 1)
- The segment encompassed only one UCSC (University of California-Santa Cruz genome bioinformatics database) gene: HDGFL1 (Homo sapiens hepatoma derived growth factor like 1, GB #AL033539). (PMID:20509080)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Hdgfl1 | ENSMUSG00000045835 |
Paralogs (4): HDGF (ENSG00000143321), PSIP1 (ENSG00000164985), HDGFL3 (ENSG00000166503), HDGFL2 (ENSG00000167674)
Protein
Protein identifiers
Hepatoma-derived growth factor-like protein 1 — Q5TGJ6 (reviewed: Q5TGJ6)
Alternative names: PWWP domain-containing protein 1
All UniProt accessions (2): Q5TGJ6, A0A140VJK8
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the HDGF family.
RefSeq proteins (1): NP_612641* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000313 | PWWP_dom | Domain |
Pfam: PF00855
UniProt features (12 total): sequence conflict 4, compositionally biased region 4, chain 1, domain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TGJ6-F1 | 65.59 | 0.31 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 19 (showing top):
WANG_RESPONSE_TO_BEXAROTENE_UP, GOBP_CHROMATIN_REMODELING, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, MIKKELSEN_ES_ICP_WITH_H3K4ME3, GCNP_SHH_UP_EARLY.V1_UP, WNT_UP.V1_DN, NFKBIA_TARGET_GENES, GSE11818_WT_VS_DICER_KO_TREG_UP, GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN, GSE12505_WT_VS_E2_2_HET_PDC_UP, GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN, GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP, GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_DN, GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP, GOBP_CHROMATIN_ORGANIZATION
GO Biological Process (1): chromatin remodeling (GO:0006338)
GO Molecular Function (0):
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chromatin organization | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
594 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HDGFL1 | NUCLEOLIN | P19338 | 747 |
| HDGFL1 | NSD3 | Q9BZ95 | 549 |
| HDGFL1 | IGF2BP3 | O00425 | 523 |
| HDGFL1 | CTBP1 | Q13363 | 517 |
| HDGFL1 | DDX5 | P17844 | 493 |
| HDGFL1 | CTBP2 | P56545 | 476 |
| HDGFL1 | AZU1 | P20160 | 434 |
| HDGFL1 | PWWP2B | Q6NUJ5 | 420 |
| HDGFL1 | AGER | Q15109 | 420 |
| HDGFL1 | CDCA7L | Q96GN5 | 392 |
| HDGFL1 | METTL3 | Q86U44 | 391 |
| HDGFL1 | TNF | P01375 | 356 |
| HDGFL1 | SMYD1 | Q8NB12 | 348 |
| HDGFL1 | CROT | Q9UKG9 | 344 |
| HDGFL1 | PTN | P21246 | 331 |
IntAct
0 interactions, top by confidence:
BioGRID (2): HDGFL1 (Positive Genetic), HDGFL1 (Affinity Capture-MS)
ESM2 similar proteins: A4IFM7, A8C984, B6D5P1, B6D5P6, E9PT87, O08815, O54988, O55092, O70551, O88831, P00519, P00520, P00521, P07313, P0C865, P13234, P20689, P42684, P46087, Q13164, Q14028, Q16566, Q2KI23, Q32MK0, Q3SYS4, Q3UH66, Q3UIZ8, Q3ULB5, Q4JIM5, Q4KMM3, Q4V8B0, Q5R8Z4, Q5RDG7, Q5TGJ6, Q63553, Q6AYH9, Q6PDI6, Q80XI3, Q8BHL3, Q8BWQ5
Diamond homologs: A4FUF0, F4IN78, F4IZM8, O75475, P51858, P51859, Q175F8, Q29NG1, Q32N87, Q3UMU9, Q49A26, Q562D5, Q5R7T2, Q5RKH0, Q5RKN4, Q5TGJ6, Q5XXA7, Q5XXA9, Q5ZLS7, Q66T72, Q6P4K1, Q7Q161, Q7Z4V5, Q812D1, Q8MJG1, Q8VHK7, Q922P9, Q923W4, Q925G1, Q99JF8, Q9JMG7, Q9LEY4, Q9XER9, Q9XSK7, Q9Y3E1, Q8T079, F4I907, Q9LSV0, P54276, P77161
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
89 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:22570156:A:T | donor_gain | 0.7400 |
| 6:22570272:G:GT | donor_gain | 0.6200 |
| 6:22570083:G:GT | donor_gain | 0.5900 |
| 6:22570059:G:GT | donor_gain | 0.5600 |
| 6:22570080:G:GT | donor_gain | 0.5500 |
| 6:22570155:G:GT | donor_gain | 0.5300 |
| 6:22570251:G:GT | donor_gain | 0.5100 |
| 6:22570254:G:GT | donor_gain | 0.5100 |
| 6:22570250:G:GT | donor_gain | 0.5000 |
| 6:22570239:G:GT | donor_gain | 0.4600 |
| 6:22570251:G:T | donor_gain | 0.4400 |
| 6:22570255:A:T | donor_gain | 0.4400 |
| 6:22570404:G:GT | donor_gain | 0.4400 |
| 6:22570236:G:GT | donor_gain | 0.4300 |
| 6:22570266:G:GT | donor_gain | 0.4300 |
| 6:22570154:GGAGA:G | donor_gain | 0.4200 |
| 6:22570107:G:GT | donor_gain | 0.4100 |
| 6:22570300:C:T | donor_gain | 0.4000 |
| 6:22570177:TG:T | donor_gain | 0.3900 |
| 6:22570178:GG:G | donor_gain | 0.3900 |
| 6:22570174:C:CA | acceptor_gain | 0.3800 |
| 6:22570324:GCCT:G | donor_gain | 0.3800 |
| 6:22570290:C:T | donor_gain | 0.3700 |
| 6:22570347:G:GT | donor_gain | 0.3700 |
| 6:22570157:GA:G | donor_gain | 0.3600 |
| 6:22570159:G:GG | donor_gain | 0.3600 |
| 6:22570161:C:A | donor_gain | 0.3600 |
| 6:22570328:G:GG | donor_gain | 0.3600 |
| 6:22570330:A:AT | donor_gain | 0.3600 |
| 6:22569993:G:GT | donor_gain | 0.3500 |
AlphaMissense
1657 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:22569621:T:C | F16L | 1.000 |
| 6:22569623:T:A | F16L | 1.000 |
| 6:22569623:T:G | F16L | 1.000 |
| 6:22569650:G:C | W25C | 0.999 |
| 6:22569650:G:T | W25C | 0.999 |
| 6:22569651:C:T | P26S | 0.999 |
| 6:22569699:T:C | F42L | 0.999 |
| 6:22569700:T:C | F42S | 0.999 |
| 6:22569701:C:A | F42L | 0.999 |
| 6:22569701:C:G | F42L | 0.999 |
| 6:22569702:T:C | F43L | 0.999 |
| 6:22569704:C:A | F43L | 0.999 |
| 6:22569704:C:G | F43L | 0.999 |
| 6:22569798:T:C | F75L | 0.999 |
| 6:22569799:T:C | F75S | 0.999 |
| 6:22569800:C:A | F75L | 0.999 |
| 6:22569800:C:G | F75L | 0.999 |
| 6:22569622:T:C | F16S | 0.998 |
| 6:22569622:T:G | F16C | 0.998 |
| 6:22569648:T:A | W25R | 0.998 |
| 6:22569648:T:C | W25R | 0.998 |
| 6:22569652:C:A | P26Q | 0.998 |
| 6:22569702:T:A | F43I | 0.998 |
| 6:22569706:G:A | G44E | 0.998 |
| 6:22569621:T:A | F16I | 0.997 |
| 6:22569621:T:G | F16V | 0.997 |
| 6:22569651:C:A | P26T | 0.997 |
| 6:22569696:T:C | F41L | 0.997 |
| 6:22569698:T:A | F41L | 0.997 |
| 6:22569698:T:G | F41L | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000464669 (6:22570748 C>G), RS1000502278 (6:22569112 G>A), RS1001535947 (6:22568167 A>G), RS1002135267 (6:22571746 G>A), RS1002470459 (6:22570476 G>A), RS1002563895 (6:22570354 C>A,T), RS1004347313 (6:22571560 C>T), RS1004580542 (6:22569213 A>T), RS1004654192 (6:22569426 G>A,C,T), RS1004668002 (6:22570506 C>T), RS1005019426 (6:22570892 A>G), RS1005582896 (6:22570141 C>A,G), RS1006286894 (6:22569863 C>G,T), RS1006650855 (6:22568264 A>G), RS1006664683 (6:22571303 C>A,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
15 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002800_2 | Number of children (6+ vs. 0 or 1) | 1.000000e-06 |
| GCST004750_77 | Squamous cell lung carcinoma | 3.000000e-06 |
| GCST004787_9 | Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) | 2.000000e-09 |
| GCST008114_27 | Type 2 diabetes | 2.000000e-06 |
| GCST009391_901 | Metabolite levels | 7.000000e-06 |
| GCST010002_49 | Refractive error | 6.000000e-38 |
| GCST010320_113 | PR interval | 4.000000e-15 |
| GCST010321_9 | PR interval | 6.000000e-18 |
| GCST010479_73 | Coronary artery disease | 5.000000e-09 |
| GCST010796_5327 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-09 |
| GCST010796_5328 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-08 |
| GCST010796_5329 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-08 |
| GCST010866_110 | Coronary artery disease | 3.000000e-18 |
| GCST010989_260 | Body size at age 10 | 2.000000e-09 |
| GCST011365_130 | Myocardial infarction | 2.000000e-06 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006918 | female fertility |
| EFO:0010441 | triacylglycerol 58:7 measurement |
| EFO:0004462 | PR interval |
| EFO:0004327 | electrocardiography |
| EFO:0009819 | comparative body size at age 10, self-reported |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases expression, increases abundance | 2 |
| Valproic Acid | affects cotreatment, increases expression, decreases methylation | 2 |
| Cadmium Chloride | increases expression, increases abundance | 2 |
| Particulate Matter | increases abundance, decreases expression | 2 |
| CGP 52608 | increases reaction, affects binding | 1 |
| bisphenol S | decreases methylation | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.